CORTNEY BERKLEY: Open Payments
NPI 1629447859 · BRECKENRIDGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 11 payments from 6 companies in 2025. Trend: 2023 $474 · 2024 $181 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $106 |
| ABBVIE INC. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: INGREZZA, VRAYLAR, INVEGA SUSTENNA, CAPLYTA, REXULTI, Auvelity.
Industry payments across TX — which companies pay providers there.
